메뉴 건너뛰기




Volumn 163, Issue 7, 2011, Pages 1495-1506

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ 9-THCV in animal models of Parkinson's disease

Author keywords

9 THCV; 6 hydroxydopamine lesioned rats; cannabinoid receptors; LPS lesioned mice; neuroprotection; Parkinson's disease

Indexed keywords

CANNABIDIOL; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; DELTA 9 TETRAHYDROCANNABIVARIN; DOPAMINE; GLUTAMIC ACID; LIPOPOLYSACCHARIDE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; CANNABINOID 1 RECEPTOR; DELTA TETRAHYDROCANNABIVARIN; NEUROPROTECTIVE AGENT; RIMONABANT;

EID: 79960300079     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01278.x     Document Type: Article
Times cited : (173)

References (37)
  • 1
    • 58149114715 scopus 로고    scopus 로고
    • Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity
    • Adermark L, Talani G, Lovinger DM, (2009). Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci 29: 32-41.
    • (2009) Eur J Neurosci , vol.29 , pp. 32-41
    • Adermark, L.1    Talani, G.2    Lovinger, D.M.3
  • 4
    • 38349099590 scopus 로고    scopus 로고
    • The peripheral cannabinoid receptor knockout mice: An update
    • Buckley NE, (2008). The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 153: 309-318.
    • (2008) Br J Pharmacol , vol.153 , pp. 309-318
    • Buckley, N.E.1
  • 6
    • 0033936028 scopus 로고    scopus 로고
    • Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
    • Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM, (2000). Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14: 1432-1438. (Pubitemid 30439752)
    • (2000) FASEB Journal , vol.14 , Issue.10 , pp. 1432-1438
    • Di Marzo, V.1    Hill, M.P.2    Bisogno, T.3    Crossman, A.R.4    Brotchie, J.M.5
  • 7
    • 2442677617 scopus 로고    scopus 로고
    • Experimental Parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: A modulator of endocannabinoid function
    • DOI 10.1038/sj.npp.1300407
    • Fernández-Espejo E, Caraballo I, Rodriguez de Fonseca F, Ferrer B, El Banoua F, Flores JA, et al,. (2004). Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. Neuropsychopharmacology 29: 1134-1142. (Pubitemid 38670050)
    • (2004) Neuropsychopharmacology , vol.29 , Issue.6 , pp. 1134-1142
    • Fernandez-Espejo, E.1    Caraballo, I.2    Rodriguez De Fonseca, F.3    Ferrer, B.4    El Banoua, F.5    Flores, J.A.6    Galan-Rodriguez, B.7
  • 8
  • 9
    • 0141481993 scopus 로고    scopus 로고
    • Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias
    • DOI 10.1046/j.1460-9568.2003.02896.x
    • Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A, (2003). Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18: 1607-1614. (Pubitemid 37215113)
    • (2003) European Journal of Neuroscience , vol.18 , Issue.6 , pp. 1607-1614
    • Ferrer, B.1    Asbrock, N.2    Kathuria, S.3    Piomelli, D.4    Giuffrida, A.5
  • 10
    • 33846401540 scopus 로고    scopus 로고
    • Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
    • DOI 10.1016/j.brainres.2006.11.063, PII S0006899306034718
    • García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J, (2007). Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134: 162-170. (Pubitemid 46135535)
    • (2007) Brain Research , vol.1134 , Issue.1 , pp. 162-170
    • Garcia-Arencibia, M.1    Gonzalez, S.2    De Lago, E.3    Ramos, J.A.4    Mechoulam, R.5    Fernandez-Ruiz, J.6
  • 11
    • 43549124297 scopus 로고    scopus 로고
    • Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
    • García-Arencibia M, Ferraro L, Tanganelli S, Fernández-Ruiz J, (2008). Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats. Neurosci Lett 438: 10-13.
    • (2008) Neurosci Lett , vol.438 , pp. 10-13
    • García-Arencibia, M.1    Ferraro, L.2    Tanganelli, S.3    Fernández-Ruiz, J.4
  • 13
    • 33644952242 scopus 로고    scopus 로고
    • Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
    • González S, Scorticati C, García-Arencibia M, de Miguel R, Ramos JA, Fernández-Ruiz J, (2006). Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. Brain Res 1073-1074: 209-219.
    • (2006) Brain Res , vol.1073-1074 , pp. 209-219
    • González, S.1    Scorticati, C.2    García-Arencibia, M.3    De Miguel, R.4    Ramos, J.A.5    Fernández-Ruiz, J.6
  • 15
    • 66049127133 scopus 로고    scopus 로고
    • Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
    • Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA, et al,. (2009). Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res 87: 1913-1921.
    • (2009) J Neurosci Res , vol.87 , pp. 1913-1921
    • Hunter, R.L.1    Cheng, B.2    Choi, D.Y.3    Liu, M.4    Liu, S.5    Cass, W.A.6
  • 16
    • 46149095463 scopus 로고    scopus 로고
    • The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: Implications in Parkinson's disease
    • Jiménez-Del-Rio M, Daza-Restrepo A, Velez-Pardo C, (2008). The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease. Neurosci Res 61: 404-411.
    • (2008) Neurosci Res , vol.61 , pp. 404-411
    • Jiménez-Del-Rio, M.1    Daza-Restrepo, A.2    Velez-Pardo, C.3
  • 17
    • 67649644733 scopus 로고    scopus 로고
    • The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
    • Kelsey JE, Harris O, Cassin J, (2009). The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. Behav Brain Res 203: 304-307.
    • (2009) Behav Brain Res , vol.203 , pp. 304-307
    • Kelsey, J.E.1    Harris, O.2    Cassin, J.3
  • 18
    • 0035545362 scopus 로고    scopus 로고
    • 1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
    • DOI 10.1046/j.0953-816X.2001.01812.x
    • Lastres-Becker I, Cebeira M, de Ceballos M, Zeng B-Y, Jenner P, Ramos JA, et al,. (2001). Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci 14: 1827-1832. (Pubitemid 35463701)
    • (2001) European Journal of Neuroscience , vol.14 , Issue.11 , pp. 1827-1832
    • Lastres-Becker, I.1    Cebeira, M.2    De Ceballos, M.L.3    Zeng, B.-Y.4    Jenner, P.5    Ramos, J.A.6    Fernandez-Ruiz, J.J.7
  • 19
    • 17444370570 scopus 로고    scopus 로고
    • Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
    • DOI 10.1016/j.nbd.2004.11.009
    • Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J, (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis 19: 96-107. (Pubitemid 40544727)
    • (2005) Neurobiology of Disease , vol.19 , Issue.1-2 , pp. 96-107
    • Lastres-Becker, I.1    Molina-Holgado, F.2    Ramos, J.A.3    Mechoulam, R.4    Fernandez-Ruiz, J.5
  • 21
    • 0027482872 scopus 로고
    • Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: An in situ hybridization study
    • DOI 10.1111/j.1471-4159.1993.tb09807.x
    • Mailleux P, Vanderhaeghen JJ, (1993). Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. J Neurochem 61: 1705-1712. (Pubitemid 23317193)
    • (1993) Journal of Neurochemistry , vol.61 , Issue.5 , pp. 1705-1712
    • Mailleux, P.1    Vanderhaeghen, J.-J.2
  • 24
    • 38449091547 scopus 로고    scopus 로고
    • Biochemistry of postmortem brains in Parkinson's disease: Historical overview and future prospects
    • Nagatsu T, Sawada M, (2007). Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl 72: 113-120.
    • (2007) J Neural Transm Suppl , vol.72 , pp. 113-120
    • Nagatsu, T.1    Sawada, M.2
  • 25
    • 33846677995 scopus 로고    scopus 로고
    • An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats
    • DOI 10.1007/s00726-006-0317-y, Special Issue: Focus on Metabotropic Glutamate Receptors
    • Ossowska K, Konieczny J, Wardas J, Pietraszek M, Kuter K, Wolfarth S, et al,. (2007). An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Amino Acids 32: 179-188. (Pubitemid 46198741)
    • (2007) Amino Acids , vol.32 , Issue.2 , pp. 179-188
    • Ossowska, K.1    Konieczny, J.2    Wardas, J.3    Pietraszek, M.4    Kuter, K.5    Wolfarth, S.6    Pilc, A.7
  • 27
    • 79953042017 scopus 로고    scopus 로고
    • Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors
    • Pérez-Rial S, García-Gutiérrez MS, Molina JA, Pérez-Nievas BG, Ledent C, Leiva C, et al,. (2010). Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors. Neurobiol Aging 32: 631-645.
    • (2010) Neurobiol Aging , vol.32 , pp. 631-645
    • Pérez-Rial, S.1    García-Gutiérrez, M.S.2    Molina, J.A.3    Pérez-Nievas, B.G.4    Ledent, C.5    Leiva, C.6
  • 29
    • 77249168348 scopus 로고    scopus 로고
    • Levodopa in Parkinson's disease: From the past to the future
    • Pezzoli G, Zini M, (2010). Levodopa in Parkinson's disease: from the past to the future. Expert Opin Pharmacother 11: 627-635.
    • (2010) Expert Opin Pharmacother , vol.11 , pp. 627-635
    • Pezzoli, G.1    Zini, M.2
  • 31
    • 66449132820 scopus 로고    scopus 로고
    • WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
    • Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernández E, et al,. (2009). WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci 29: 2177-2186.
    • (2009) Eur J Neurosci , vol.29 , pp. 2177-2186
    • Price, D.A.1    Martinez, A.A.2    Seillier, A.3    Koek, W.4    Acosta, Y.5    Fernández, E.6
  • 32
    • 0035077354 scopus 로고    scopus 로고
    • Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: An animal model of Parkinson's disease
    • DOI 10.1016/S0166-4328(01)00168-1, PII S0166432801001681
    • Rodriguez Diaz M, Abdala P, Barroso-Chinea P, Obeso J, González-Hernández T, (2001). Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. Behav Brain Res 122: 79-92. (Pubitemid 32238177)
    • (2001) Behavioural Brain Research , vol.122 , Issue.1 , pp. 79-92
    • Rodriguez Diaz, M.1    Abdala, P.2    Barroso-Chinea, P.3    Obeso, J.4    Gonzalez-Hernandez, T.5
  • 34
    • 0033538482 scopus 로고    scopus 로고
    • Motor actions of cannabinoids in the basal ganglia output nuclei
    • DOI 10.1016/S0024-3205(99)00293-3, PII S0024320599002933
    • Sañudo-Peña MC, Tsou K, Walker JM, (1999). Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci 65: 703-713. (Pubitemid 29362776)
    • (1999) Life Sciences , vol.65 , Issue.6-7 , pp. 703-713
    • Sanudo-Pena, M.C.1    Tsou, K.2    Walker, J.M.3
  • 35
    • 0344406282 scopus 로고    scopus 로고
    • Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease
    • DOI 10.1002/mds.10312
    • Segovia G, Mora F, Crossman AR, Brotchie JM, (2003). Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease. Mov Disord 18: 138-149. (Pubitemid 36305456)
    • (2003) Movement Disorders , vol.18 , Issue.2 , pp. 138-149
    • Segovia, G.1    Mora, F.2    Crossman, A.R.3    Brotchie, J.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.